Ofloxacin PCD Pharma Franchise Company
Cafoli Lifecare is a leading Ofloxacin PCD pharma franchise company in India, with 63 Ofloxacin formulations — one of the broadest single-molecule ranges in our portfolio. Products span tablets, dry syrup, syrup, suspension, injection, infusion, eye drops, eye ointment, ear drops and cream, all manufactured at WHO-GMP certified, DCGI-approved facilities and offered with exclusive district-wise monopoly rights.
What is Ofloxacin?
Ofloxacin is a broad-spectrum fluoroquinolone antibacterial. It inhibits bacterial DNA gyrase and topoisomerase IV, the enzymes responsible for supercoiling and separating bacterial DNA during replication, which halts DNA synthesis and kills the organism. Its activity covers a wide range of Gram-negative and many Gram-positive bacteria, and its favourable tissue penetration allows it to be used systemically as well as topically in the eye, ear and skin. It is listed on the WHO Model List of Essential Medicines.
Available Ofloxacin Formulations
The Cafoli Lifecare Ofloxacin range comprises 63 formulations in the following dosage forms:
- Tablets
- Dry Syrup and Syrup
- Suspension
- Injection and Infusion
- Eye Drops and Eye Ointment
- Eye/Ear Drops
- Cream
Brand names, compositions, pack sizes and net rates are shared with registered franchise enquiries. Contact our team for the complete Ofloxacin price list.
Therapeutic Applications of Ofloxacin
Prescribed under medical supervision for:
- Infective diarrhoea and bacterial gastroenteritis, including mixed aerobic-anaerobic infections in combination with Ornidazole
- Urinary tract infections and bacterial prostatitis
- Lower respiratory tract infections
- Skin and soft tissue infections
- Bacterial conjunctivitis, keratitis and other ocular infections (drops and ointment)
- Otitis externa and bacterial ear infections (ear drops)
- Paediatric bacterial infections, as dry syrup or suspension
Prescriber specialties: consulting physicians, paediatricians, gastroenterologists, urologists, ENT specialists, ophthalmologists, dermatologists and surgeons. Ofloxacin is a prescription-only antibiotic and should be used in line with antimicrobial stewardship guidance, observing the fluoroquinolone class warnings on tendon and neurological effects.
Why Ofloxacin is a High-Potential Molecule for Distributors
Ofloxacin is, for most franchise partners, the single most productive anti-infective molecule to carry — not because of any one blockbuster SKU, but because of the sheer surface area of its range. Sixty-three formulations across ten dosage forms mean one molecule can be detailed to almost every prescriber in a district: the physician gets tablets, the paediatrician gets dry syrup, the ophthalmologist gets drops, the ENT specialist gets ear drops, the surgeon gets cream, the nursing home gets injection. That converts a single monopoly allotment into a multi-speciality business and dramatically lowers the cost of covering a territory. The Ofloxacin-Ornidazole combination in particular is one of the highest-volume anti-infective categories in Indian pharma, driven by the very high incidence of infective diarrhoea, and it spikes reliably during the monsoon. Fast stock turns, a broad prescriber base and one of the deepest SKU lists available make Ofloxacin the natural volume engine of a new franchise territory.
Why Choose Cafoli Lifecare
- Monopoly rights — exclusive district-wise marketing rights across all 63 Ofloxacin formulations
- WHO-GMP certified manufacturing and DCGI-approved products
- Promotional inputs — visual aids, MR bags, prescription pads, samples and reminder cards
- 1000+ franchise partners across India with an on-time dispatch record
- Transparent net rates and dedicated franchise support
References
- WHO Model List of Essential Medicines
- PubChem — Ofloxacin compound record
- PubMed — Ofloxacin and Ofloxacin-Ornidazole clinical literature
Our formulations of Ofloxacin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: